AIM: We investigated whether omega-3 fatty acid intake and erythrocyte membrane omega-3 fatty acid levels are associated with conversion to type 1 diabetes in children with islet autoimmunity (IA). METHODS: The Diabetes Autoimmunity Study in the Young is following children at increased genetic risk for type 1 diabetes for the development of persistent IA, as defined as being positive for glutamic acid decarboxylase 65, i, or insulin autoantibodies on two consecutive visits, and then for the development of type 1 diabetes, as diagnosed by a physician. One hundred and sixty-seven children with persistent IA were followed for a mean of 4.8 yr, and 45 of these developed type 1 diabetes at a mean age of 8.7 yr. Erythrocyte membrane fatty acids (as a percent of total lipid) and dietary fatty acid intake (estimated via food frequency questionnaire) were analyzed as time-varying covariates in proportional hazards survival analysis, with follow-up time starting at detection of the first autoantibody. RESULTS: Neither dietary intake of omega-3 fatty acids nor omega-6 fatty acids were associated with conversion to type 1 diabetes, adjusting for human leukocyte antigen (HLA)-DR, family history of type 1 diabetes, age at first IA positivity, maternal age, maternal education, and maternal ethnicity. Adjusting for HLA-DR, family history of type 1 diabetes and age at first IA positivity, omega-3 and omega-6 fatty acid levels of erythrocyte membranes were not associated with conversion to type 1 diabetes. CONCLUSIONS: In this observational study, omega-3 fatty acid intake and status are not associated with conversion to type 1 diabetes in children with IA.
AIM: We investigated whether omega-3 fatty acid intake and erythrocyte membrane omega-3 fatty acid levels are associated with conversion to type 1 diabetes in children with islet autoimmunity (IA). METHODS: The Diabetes Autoimmunity Study in the Young is following children at increased genetic risk for type 1 diabetes for the development of persistent IA, as defined as being positive for glutamic acid decarboxylase 65, i, or insulin autoantibodies on two consecutive visits, and then for the development of type 1 diabetes, as diagnosed by a physician. One hundred and sixty-seven children with persistent IA were followed for a mean of 4.8 yr, and 45 of these developed type 1 diabetes at a mean age of 8.7 yr. Erythrocyte membrane fatty acids (as a percent of total lipid) and dietary fatty acid intake (estimated via food frequency questionnaire) were analyzed as time-varying covariates in proportional hazards survival analysis, with follow-up time starting at detection of the first autoantibody. RESULTS: Neither dietary intake of omega-3 fatty acids nor omega-6 fatty acids were associated with conversion to type 1 diabetes, adjusting for human leukocyte antigen (HLA)-DR, family history of type 1 diabetes, age at first IA positivity, maternal age, maternal education, and maternal ethnicity. Adjusting for HLA-DR, family history of type 1 diabetes and age at first IA positivity, omega-3 and omega-6 fatty acid levels of erythrocyte membranes were not associated with conversion to type 1 diabetes. CONCLUSIONS: In this observational study, omega-3 fatty acid intake and status are not associated with conversion to type 1 diabetes in children with IA.
Authors: H Iso; K M Rexrode; M J Stampfer; J E Manson; G A Colditz; F E Speizer; C H Hennekens; W C Willett Journal: JAMA Date: 2001-01-17 Impact factor: 56.272
Authors: Jill M Norris; Katherine Barriga; Georgeanna Klingensmith; Michelle Hoffman; George S Eisenbarth; Henry A Erlich; Marian Rewers Journal: JAMA Date: 2003-10-01 Impact factor: 56.272
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Randi K Johnson; Lauren A Vanderlinden; Brian C DeFelice; Ulla Uusitalo; Jennifer Seifert; Sili Fan; Tessa Crume; Oliver Fiehn; Marian Rewers; Katerina Kechris; Jill M Norris Journal: Pediatr Diabetes Date: 2020-08-09 Impact factor: 4.866
Authors: Archana P Lamichhane; Jamie L Crandell; Lindsay M Jaacks; Sarah C Couch; Jean M Lawrence; Elizabeth J Mayer-Davis Journal: Am J Clin Nutr Date: 2015-05-06 Impact factor: 7.045
Authors: Sari Niinistö; Hanna-Mari Takkinen; Iris Erlund; Suvi Ahonen; Jorma Toppari; Jorma Ilonen; Riitta Veijola; Mikael Knip; Outi Vaarala; Suvi M Virtanen Journal: Diabetologia Date: 2017-05-04 Impact factor: 10.122
Authors: H Peter Chase; David Boulware; Henry Rodriguez; David Donaldson; Sonia Chritton; Lisa Rafkin-Mervis; Jeffrey Krischer; Jay S Skyler; Michael Clare-Salzler Journal: Pediatr Diabetes Date: 2014-07-12 Impact factor: 4.866
Authors: Ismail Syed; Maria F Rubin de Celis; James F Mohan; Pedro M Moraes-Vieira; Archana Vijayakumar; Andrew T Nelson; Dionicio Siegel; Alan Saghatelian; Diane Mathis; Barbara B Kahn Journal: J Clin Invest Date: 2019-08-05 Impact factor: 14.808
Authors: Jill M Norris; Miranda Kroehl; Tasha E Fingerlin; Brittni N Frederiksen; Jennifer Seifert; Randall Wong; Michael Clare-Salzler; Marian Rewers Journal: Diabetologia Date: 2013-11-16 Impact factor: 10.122